Covalon Announces Share Consolidation

About this update from Covalon Technologies Ltd.

[{"type":"text","content":"\n\n\nMISSISSAUGA, ON, July 15, 2013 /CNW/ - Covalon Technologies Ltd. (the\n \"Company\") (TSXV: COV), an advanced medical technologies company,\n announces that it has filed articles of amendment to consolidate the\n issued and outstanding common shares of the Company (\"Shares\") on the\n basis of one post-consolidation Share for each 10 pre-consolidation\n Shares. The consolidation was approved by the Company's shareholders at\n the annual and special meeting held on June 13, 2013 and the approval\n of the TSX Venture Exchange (\"TSXV\") has also been obtained. The Shares\n will commence trading on the TSXV on a consolidated basis effective at\n the opening on Tuesday, July 16, 2013.  The Shares will continue\n trading under the same stock symbol, COV.\n\n\nAbout Covalon\n\n\nCovalon Technologies Ltd. researches, develops and commercializes new\n healthcare technologies that help save lives around the world.\n Covalon's patented technologies, products and services address the\n advanced healthcare needs of medical device companies, healthcare\n providers and individual consumers. Covalon's technologies are used to\n prevent, detect and manage medical conditions in specialty areas such\n as wound care, tissue repair, infection control, disease management,\n medical device coatings and biocompatibility. To learn more about\n Covalon, visit our website at www.covalon.com.\n\n\nNeither TSX Venture Exchange nor its Regulation Services Provider (as\n that term is defined in the policies of the TSX Venture Exchange)\n accepts responsibility for the adequacy or accuracy of this release. \n\n\nThis news release contains forward-looking statements which reflect the\n Company's current expectations regarding future events. The\n forward-looking statements are often, but not always, identified by the\n use of words such as \"seek\", \"anticipate\", \"plan\", \"estimate\",\n \"expect\", \"intend\" and statements that an event or result \"may\",\n \"will\", \"should\", \"could\" or \"might\" occur or be achieved and other\n similar expressions. These forward-looking statements involve risk and\n uncertainties, including the difficulty in predicting product\n approvals, acceptance of and demands for new products, the impact of\n the products and pricing strategies of competitors, delays in\n developing and launching new products, the ...

More updates from Covalon Technologies Ltd.